Mark Bounthavong, PharmD, MPH
Graduate student
University of Washington
Pharmaceutical Outcomes Research and Policy Program
H375 Health Science Building
Seattle,
WA
USA
98195-7630
Papers:
1C-4
PHARMACOGENOMICS IMPLEMENTATION: QUANTITATIVE COMPARISON OF EVIDENCE LEVELS FOR PHARMACOGENOMIC- VS. CLINICAL-BASED PERSONALIZED MEDICINE